Skip to main content

Table 1 Baseline and clinical characteristics of study population in the control and DCM diseased group

From: Detection and comparison of microRNA expression in the serum of Doberman Pinschers with dilated cardiomyopathy and healthy controls

 

Control (n = 4)

DCM (n = 4)

Age (years)

9.3 ± 2.1

7.9 ± 3.3

Body weight (kg)

39.3 ± 8.9

36.6 ± 4.5

Gender (male/female)

2/2

3/1

VPCs/24 hours

12.75 ± 15.39

2748 ± 4842*

LVEDV (ml/m 2 )

67.68 ± 11.60

120.30 ± 3.85*

LVESV (ml/m 2 )

33.63 ± 7.45

72.50 ± 2.85*

EF (%)

49.83 ± 6.37

39.67 ± 3.68*

Urea (mmol/l)

6.00 ± 0.68

4.80 ± 1.22

Creatinine (μmol/l)

62.25 ± 6.40

65.00 ± 6.58

cTnI (ng/ml)

≤ 0.20

0.36 ± 0.04*

total RNA (ng/μl)

3.63 ± 0.33

4.23 ± 1.23

  1. Age, body weight, VPCs, LVEDV, LVESV, EF, urea, creatinine, cTnI and total RNA values in mean ± SD. cTnI ≤ 0.2 representing values under the detectable limit. DCM: Dilated cardiomyopathy; VPCs/24 hours: ventricular premature complexes in 24 hours; LVEDV: left ventricular end-diastolic volume; LVESV: left ventricular end-systolic volume; EF: left ventricular ejection fraction; cTnI: cardiac troponin I; RNA: Ribonucleic acid. * p < 0.05 vs control.